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Background: The use of carotid stenting in octogenarian patients is controversial; some authors consider this population
at high risk for the procedure. Anatomic vascular complexity may be an important reason for the high reported rates of
periprocedural thromboembolic complications. Transcervical carotid angioplasty and stenting (TCS) with flow reversal
avoids aortic arch instrumentation. In this study, we analyzed our experience with TCS in octogenarian patients and
compared the results with those of carotid endarterectomy (CEA) in the same age group in terms of safety.
Methods: The study included 81 patients, >80 years, a retrospective cohort of 45 consecutive patients treated with CEA
(January 2002 to January 2005), and a prospective cohort of 36 consecutive patients treated with TCS with protective
flow reversal (January 2005 to January 2007). Patients were considered symptomatic according to the North American
Symptomatic Carotid Endarterectomy Trial (NASCET) criteria. Stenting indication was established on the SAPPHIRE
criteria. General anesthesia was used in patients undergoing CEA, and local anesthesia in those receiving TCS. Primary
endpoints were: stroke, death, or acute myocardial infarction within 30 days. Secondary endpoints were peripheral nerve
paralysis and cervical hematoma. Statistical significance for between-group differences was assessed by Pearson 2 or
Fisher exact test, and Student t test. A P value of <.05 was considered statistically significant. Follow-up was limited to
30 days.
Results: Baseline epidemiological characteristics and revascularization indications were similar between both groups.
Mean age was significantly higher in the TCS group (83.5  3.35) than the CEA group (81.7  1.55) (P  .004).
Percentage of symptomatic lesions was similar: 30.6% in TCS vs 44.4% in CEA (P  .2). Comorbid conditions
(respiratory or cardiac) were more frequent in TCS group (61.6% vs 26.6%; P  .002). There were no significant
differences between groups for the primary endpoints: 4.4% (one stroke, one acute myocardial infarction) for CEA vs 0%
for TCS (P .5). Among CEA patients, there were two peripheral nerve palsies (4.4%) and one cervical hematoma (2.2%);
there were no such complications with TCS (P .5 and P 1, respectively). In one asymptomatic TCS patient, Doppler
study at 24 hours following the procedure showed a common carotid artery dissection, which was treated by a common
carotid to internal carotid bypass.
Conclusions: In this preliminary experience, transcervical carotid angioplasty and stenting with flow reversal for cerebral
protection was as safe at short term as carotid endarterectomy in octogenarian patients, who additionally had considerable
comorbidity; thus, it may be possible to extend the indications for carotid revascularization in this population. Studies in
larger patient series are required to confirm the trends observed in this study. (J Vasc Surg 2008;47:96-100.)Over the last decade, carotid angioplasty and stenting
has emerged as a promising new technique for the treat-
ment of carotid stenosis. Nonetheless, it has been sug-
gested that patients of advanced age may constitute a
high-risk subgroup for stenting. Various individual experi-
ences1,2 and particularly the preliminary results of the
lead-in phase of the Carotid Revascularization Endartec-
tomy versus Stenting Trial (CREST)3 study, seem to con-
firm this idea: among 749 patients, the rate of periproce-
dural stroke in octogenarians was 12.1% compared with
2.77% in younger patients. Only one multicenter effort, the
SAPPHIRE4 study, in which more that 20% of the patients
treated were octogenarians, reported noninferiority of ca-
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96rotid stenting vs carotid endarterectomy (CEA) in this
subgroup of patients.
Apart from individual experiences with CEA in octoge-
narians, this age group has been historically excluded from
multicenter trials comparing endarterectomy and the best
medical therapy.5,6,7 In addition, although CEA is re-
ported to be safe in octogenarians,8 the best treatment
option for this population has not been established in
randomized studies. The higher rate of complications with
the use of transfemoral carotid stenting in elderly patients
has been attributed in part to the greater technical difficulty
of this treatment. The anatomy of the aortic arch can be
complex in this age group and tortuosity of the supra-aortic
trunks is common, making access difficult and potentially
increasing the risk of periprocedural distal embolization.9
In contrast, transcervical carotid stenting (TCS) with flow
reversal for cerebral protection allows deployment of the
stent over the stenotic lesion without aortic arch instru-
mentation.10,11
The aim of this study was to analyze the results of TCS
with flow reversal compared with CEA in a homogeneous
group of octogenarian patients, based on the hypothesis
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tortuous vessels, TCS can be as safe as CEA in this patient
population.
PATIENTS AND METHODS
The study included 81 patients, all at least 80 years old,
who were treated for 70% carotid stenosis in our institu-
tion over a period of 5 years. Carotid endarterectomy was
performed in 45 consecutive cases treated during January
2002 to January 2005. In 2005, our hospital Ethics Com-
mittee approved the transcervical carotid stenting protocol,
and 36 consecutive patients were treated with this tech-
nique from January 2005 to January 2007. Our protocol
establishes that carotid stenting should only be performed
in patients deemed at high surgical risk according to the
SAPPHIRE criteria.4 Hence, any candidate for carotid
revascularization over 80 years old would undergo TCS,
except cases with unfavorable factors for this treatment: ie,
internal carotid kinking distal to the stenosis, preocclusive
lesions difficult to cross with the stent, or presence of severe
atheromatosis in the common carotid artery. Six patients
with these characteristics were treated by CEA or trans-
femoral carotid angioplasty and stenting during the period
specified and were not included in the series presented.
All the study patients received detailed information on
the potential risks of the interventions and all provided
signed consent for the procedures. Data collection for
patients who underwent CEA was retrospective and in-
volved a meticulous analysis of the medical records. The
variables analyzed in patients treated with TCS were col-
lected prospectively.
In addition to standard epidemiological variables (eg,
age and gender), the protocol for data collection included
the following classic cardiovascular risk factors: (1) hyper-
tension, defined as systolic blood pressure 140 mm Hg or
diastolic blood pressure 90 mm Hg or current use of
antihypertensive medication; (2) diabetes mellitus, defined
as a glycosylated hemoglobin A1c concentration 5.8% or
current use of hypoglycemic agents; (3) hypercholesterol-
emia, defined as a total cholesterol concentration 220
mg/dL or current use of cholesterol-lowering agents, and
(4) smoker, defined by current smoking or cessation of
smoking 1 month before entering the study. Further-
more, we investigated the presence of severe pulmonary
disease and heart disease (congestive heart failure, abnor-
mal stress test, open-heart surgery). The North American
Symptomatic Carotid Endarterectomy Trial (NASCET)
criteria6 were used to classify patients as neurologically
symptomatic or asymptomatic for the study. Stenosis sever-
ity was determined by Doppler ultrasound (DUS) (Philips
HD 11, Bothell, Wash) of the carotid artery or by brain
angiography in selected cases:12 patients with more than
70% stenosis on one side and more than 50% on the other,
those with contralateral occlusion, and those with incon-
clusive findings on the DUS examination.
In addition to the DUS study, patients undergoing
TCS were examined with magnetic resonance angiography
(MRA) to assess lesion morphology, presence of tortuousvessels, and status of the intracerebral circulation. The brain
parenchyma was examined by computed tomography (CT)
or magnetic resonance imaging (MRI). Patients treated
with TCS also underwent a preoperative transcranial Dopp-
ler (TCD) study (Spencer PMD-100, Spencer Technolo-
gies, Seattle, Wash) to evaluate cerebral vascular reactivity
(considered to be exhausted when mean velocity in the
middle cerebral artery increased 20% after 20 seconds of
apnea),13presence of high intensity transient signals
(HITS), and the existence of associated intracranial artery
lesions. TCD monitoring was performed during revascular-
ization to determine the presence of HITS and variations in
the middle cerebral artery flow as previously described.14 A
complete neurological examination was carried out in all
patients before and after the intervention by a stroke neu-
rologist, who was also present during all the stenting pro-
cedures to monitor the patient’s neurological function.
Complications at 30 days included neurological and
cardiac events, as well as death by any cause. The following
neurological complications were recorded: transient isch-
emic attack (TIA) (any ocular or neurological deficit lasting
less than 24 hours), minor stroke (any ocular or neurolog-
ical deficit lasting more than 24 hours and resulting a 
three-point increase on the National Institutes of Health
Stroke Scale [NIHSS]15), and major stroke (any deficit
resulting in a more than three-point increase on the same
scale). Acute myocardial infarction (AMI) was defined as
anginal chest pain plus troponin T elevation greater than
twice the upper limit of the reference value or creatine
kinase (CK-MB) fraction above normal, or the appearance
of new Q-waves on the electrocardiogram (ECG). In addi-
tion, the analysis included the presence of peripheral nerve
paralysis or dysfunction and cervical hematomas that re-
quired surgical drainage. In patients undergoing TCS, we
also analyzed technical success and stent patency at 24
hours and 30 days following the procedure as assessed by
DUS.
Surgical procedure. Carotid endarterectomy was per-
formed by several staff vascular surgeons from our hospital
with extensive experience in this intervention (40 CEAs
per year). A standard endarterectomy technique was carried
out. A patch was used to close the arteriotomy in all cases
and shunts were performed at the discretion of the surgeon.
All procedures were carried out under general anesthesia.
Transcervical carotid angioplasty and stenting. All
carotid artery stenting was done by the same vascular
surgeon. The technique used in all patients, initially de-
scribed by Criado et al,10 involves proximal occlusion of the
common carotid artery to establish flow reversal in the
internal carotid and creation of an arteriovenous shunt
between the common carotid and internal jugular vein
through a transcervical approach. Briefly, the technique
consisted of the following: under local anesthesia, a vertical
mini-incision was made at the base of the neck to access the
proximal common carotid artery, which was controlled by a
vessel loop. Following dissection of the internal jugular
vein, a shunt was created between the common carotid and
jugular vein by placing an 8F introducer sheath in each
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Under systemic heparinization, the common carotid artery
was occluded and retrograde flow was established in the
internal carotid as confirmed by TCD. We did not place a
balloon in the external carotid and in the case that internal
carotid retrograde flow was incomplete and HITS were
seen, manual aspiration was initiated. Angiography in an-
tero-posterior and oblique views was performed to quantify
the stenosis. Subsequently, a 0.014-inch guidewire was
inserted in a 40-cm long Berenstein 4F catheter (Angiody-
namics, Queensbury, NY), and the internal carotid artery
lesion was crossed through the sheath placed in the com-
mon carotid artery. Once the proximal guidewire reached
the carotid siphon, the stent was inserted and dilated with
an angioplasty balloon. Slow, manual aspiration (20 cc) was
carried out before releasing the clamp, and an angiographic
study was done to assess the technical outcome and inves-
tigate possible complications. Two types of stents were
used: Acculink (Guidant, Santa Clara, Calif) and Carotid
Wallstent (Boston Scientific, Natick, Mass). Atropine (0.5
to 1 mg) was injected in the case of important bradycardia
and intra-arterial nitroglycerin (100 to 200 g) was used
when spasm of the distal carotid occurred. Following with-
drawal of the introducers, the puncture sites were closed
with 5-0 polypropylene sutures.
All patients were prescribed acetylsalicylic acid (300
mg/d) and clopidogrel (75 mg/d) for at least 4 days before
the procedure. In cases of noncompliance with this treat-
ment, a 300-mg loading dose of clopidogrel was adminis-
tered 24 hours before the procedure. Double antiplatelet
therapy (aspirin and clopidogrel) was maintained for the
first 30 days and, thereafter, clopidogrel 75 mg/day was
prescribed indefinitely.
Statistical analysis. Descriptive and frequency statis-
tical analyses were obtained, and comparisons were made
with the SPSS statistics package, version 12.0 for Windows.
Statistical significance for between-group differences was
assessed by Pearson 2 or Fisher exact test for categorical
variables and Student t test for continuous variables. A P
value of .05 was considered statistically significant.
RESULTS
Comparative study was carried out in a total of 81
patients, 45 of whom received CEA and 36 TCS. Demo-
graphic data are shown in Table I. All the patients were over
80 years old, but age was significantly lower in the CEA
group (81.7  1.55 vs 83.5  3.35, P  .004). The two
groups were comparable with the exception of associated
comorbid conditions, which were significantly higher in the
TCS group. Cardiovascular risk factors were similar, but a
significantly smaller percentage of patients treated with
CEA had cardiovascular disease (22.2% vs 44.4%; P .03),
severe pulmonary disease (6.7% vs 30.6%, P .005), and
the combination of these conditions (26.7% vs 61.1% P
.2, compared with the stent group. There were no signif-
icant differences in the proportion of symptomatic patients
between the groups (44.4% CEA vs 30.6% TCS, P .2).
Nor were there differences in the degree of contralateralcarotid stenosis between the groups. Among TCS patients,
30.5% (11 of 36) had intracranial lesions and 19.4% (7 of
36) presented a decreased or exhausted cerebral vascular
reactivity. None of the patients presented HITS in the
preoperative examination. Information on the status of
cerebral circulation was not available in the majority of
patients undergoing CEA.
As to the type of stent, an Acculink (Guidant) was used
in 22 patients (61.2%) and a Carotid Wallstent (Boston
Scientific) in 14 patients (38.8%). The procedure was com-
pleted with technical success in all patients in the stent
group. There was one case (2.7%) of transient intolerance
to flow reversal in a symptomatic patient with contralateral
occlusion. The preoperative examination had not provided
evidence of poor collateral circulation. In this patient, we
maintained common carotid clamping only during the key
steps of the procedure (passing the guidewire, advancing
and deploying the stent, and passing and withdrawing the
angioplasty balloon). Two other patients (5.5%) experi-
enced bradycardia and hypotension related with balloon
inflation which was controlled with atropine. Severe spasm
of the distal carotid occurred in one patient (2.7%) and was
treated with intra-arterial nitroglycerin. HITS were ob-
served in one case (2.7%) at the time when the stent crossed
the lesion, and manual aspiration was performed. In 83.3%
of patients (30 of 36) flow reversal was seen in the anterior
cerebral artery and a significant antegrade flow always per-
sisted in the middle cerebral artery during carotid occlu-
sion. An increase in the mean cerebral artery flow velocity
was documented by TCD at completion of the procedure
in 100% of patients. DUS study at 24 hours showed stent
patency in 35 cases and in one patient, a major dissection in
the common carotid artery. This was treated by a bypass
from the common carotid artery to the distal internal
carotid artery. At 30 days, DUS study showed stent patency
in 35 cases and bypass patency in the single remaining case.
With regard to the clinical outcome, one patient in the
Table I. Epidemiological and clinical variables of patients
in the two treatment groups
CEA (n  45)
2002-2005
TCS (n  36)
2005-2007 P
Age (mean  SD) 81.7  1.55 83.5  3.35 .004
Gender (male) 36 (80%) 31 (86.1%) .47
Hypertension 32 (71.1%) 30 (83.3%) .2
Hyperlipidemia 15 (33.3%) 16 (44.4%) .30
Diabetes mellitas 15 (33.3%) 11 (30.6%) .79
Smoking 2 (4.4%) 3 (8.3%) .65
Coronary artery disease 10 (22.2%) 16 (44.4%) .03
Pulmonary disease 3 (6.7%) 11 (30.6%) .005
Symptomatic 20 (44.4%) 11 (30.6%) .20
Contralateral stenosis 50% 12 (26.6%) 8 (22.2%) .46
Contralateral occlusion 5 (11.1%) 5 (13.8%) .89
Intracranial lesion — 11 (30.5%) —
Decreased or exhausted
cerebral vascular reactivity — 7 (19.4%) —
TCS, Transcervical carotid angioplasty and stenting; CEA, carotid endarter-
ectomy.CEA group presented a major stroke with hemiplegia,
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events (2.2% vs 0%, P  1). One patient treated with CEA
presented acute myocardial infarction at 24 hours following
surgery; no cardiological events occurred in patients receiv-
ing TCS (2.2% vs 0%, P  1). There were no deaths in
either of the groups. No significant differences were found
in the combined stroke/AMI/death rate (4.4% vs 0%, P
.5). Peripheral neuropathic involvement occurred in two
patients in the CEA group, one presented dysphonia and
the other deviation of the tongue due to hypoglossal nerve
injury; no peripheral nerve involvement was seen in TCS
patients (4.4% vs 0%, P  .5). In addition, one patient
undergoing CEA presented a severe cervical hematoma
that required surgical drainage; there were no cases of
severe hematoma in the TCS group (2.2% vs 0% P  1).
The complications are summarized in Table II.
DISCUSSION
In this preliminary series of octogenarian patients un-
dergoing TCS with flow reversal, there were no immediate
or short-term neurological or cardiac complications and
few adverse events. The results of the intervention were
comparable with the outcome of CEA in the same age
group of patients.
The stroke/death rate at 30 days in the CEA group was
2.2%, a value comparable with reported rates by various
authors who have shown that this surgery is safe in the very
elderly population. Miller et al8 analyzed the results of a
cohort of a cohort of 1961 patients who underwent 2217
CEAs; among them, 334 were octogenarians. Although
the stroke/death rate was higher in the older subgroup
(3.1% compared with 1.5% in younger patients), the differ-
ences were not significant. In a review of the recent litera-
ture provided in the same paper, the outcome of 2204
CEAs in patients over 80 was analyzed, yielding a stroke
rate of 2.23%, operative mortality of 1.28%, and combined
stroke/death rate of 3.51%.
The use of carotid stenting in patients over 80 years old
is controversial, and several studies have shown that ad-
vanced age is associated with poorer results regarding for
this technique. Studies such as those by Kastrup et al1 and
Hobson et al3 confirmed these findings. In Kastrup’s study,
Table II. Complications in the two treatment groups
CEA TCS P
TIA 0 0 NS
Minor stroke 0 0 NS
Major stroke 1 (2.2%) 0 NS
Myocardial infarction 1 (2.2%) 0 NS
Death 0 0 NS
Cranial nerve palsy 2 (4.4%) 0 NS
Cervical hematoma 1 (2.2%) 0 NS
Major dissection in the common
carotid artery 0 1 (2.7%) NS
TCS, Transcervical carotid angioplasty and stenting;CEA, carotid endartec-
tomy; NS, not significant; TIA, transient ischemic attack.which compared the outcome of transfemoral carotid stent-ing and CEA in patients over 75 years old, the stroke rate at
30 days was significantly higher in the stenting group
(11.3%) than in the CEA group (1.8%), a fact that led the
authors to recommend limited use of stenting in very
elderly patients. The study headed by Hobson, which pre-
sents the results of the lead-in phase of the CREST trial,
concluded that the risk of stroke and death associated with
carotid stenting increases with increasing age; the rate of
stroke/death at 30 days was 12% in octogenarian patients
vs 3.2% in younger patients. In another recent study, Lam
et al9 also found a higher stroke rate in octogenarians
(8.1%) compared with patients under 80 (1.0%) undergo-
ing carotid stenting.
Several causes may explain the poorer outcome with
carotid angioplasty and stenting in octogenarian patients.
First, this population has shown greater hemodynamic
instability in relation with carotid angioplasty. Another
proposed cause of poor outcome and, in our opinion, the
main reason is the anatomical complexity of the vasculature
in these patients. A study by Lin et al16 has shown that
calcification of the aortic arch and tortuosity of the com-
mon and internal carotid arteries is frequent in octogenar-
ian patients. Along the same line, in an analysis of 1222
carotid stenting procedures, 144 performed in patients 80
years or older, Setacci et al17 also found significant differ-
ences with regard to tortuosity and calcification of the
aortic arch and supra-aortic trunks in the older patient
population compared with younger patients. In the study
by Lam et al9 analyzing 135 carotid stenting procedures,
the octogenarian cohort had a higher incidence of unfavor-
able aortic arch morphology, calcification of the arch, and
tortuosity of the common and internal carotids compared
with patients younger than 80 years of age. The authors
concluded that an unfavorable anatomy can be associated
with complications during carotid stenting.
Transcervical flow reversal averts most of the potential
problems of cerebral protection devices. Instrumentation
of the aortic arch and catheterization of the common
carotid is not required with this approach; hence, the
technical complexity of the access is reduced. Furthermore,
the angulation of the distal internal carotid does not com-
plicate establishment of good cerebral protection, because
tortuosities do not interfere with internal carotid artery
flow reversal.
One aspect of our study that warrants discussion is the
difference in associated pathologies between the two pa-
tient groups at baseline. The comparison of comorbid
clinical conditions showed that the group treated with CEA
had a significantly lower percentage of cardiac disease (22.2
% vs 44.4%, P .03), pulmonary disease (6.7% vs 30.6%, P
 .005), and the combination of these pathologies (26.7%
vs 61.1%, P.002) than the TCS group, yet there were no
postoperative complications related with the associated dis-
eases in patients receiving TCS.
The majority of patients in both treatment groups were
asymptomatic. Nevertheless, among the patients undergo-
ing TCS, 11 had an associated intracranial lesion, 5 de-
creased or exhausted cerebral vascular reactivity, 4 occlu-
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the contralateral carotid. In addition, 25% of patients in this
group had coronary artery disease and 20.8% pulmonary
disease. However, since TCS was performed under local
anesthesia, the criteria of high surgical risk did not exclude
them from the opportunity to benefit from carotid revas-
cularization. The individuals undergoing CEA were mainly
patients at low or moderate surgical risk fulfilling the crite-
ria for revascularization. In TCS patients, the findings from
preoperative assessment of the lesions by MRA and TCD,
the status of cerebral vascular reactivity, and the presence of
HITS were not predictive of outcome, although conclu-
sions cannot be established in this regard because of the
small number of patients studied.
This study has the limitation of a small sample size,
making the statistical power lower than required to derive
definitive conclusions. Nevertheless, there was a clear trend
indicating the safety and effectiveness of TCS in our series.
Despite these favorable results, however, it is likely that the
proportion of adverse events will be higher in larger patient
populations. In addition, data collection was retrospective
in the CEA group, which always implies that some infor-
mation may be missing, despite an exhaustive review of the
clinical records; nonetheless, we believe that this eventual-
ity would not affect the final results. Lastly, a long-term
clinical follow-up is needed to guarantee the efficacy and
long-lasting benefits of this procedure.
The results of this preliminary study indicate that ca-
rotid revascularization by TCS with flow reversal for cere-
bral protection is as safe as CEA at short-term in octoge-
narian patients. In contrast to the considerations of most
authors who do not recommend carotid stenting in this
patient subgroup, we believe that the high rate of reported
thromboembolic complications is mainly due to the asso-
ciated anatomical complexity of the vasculature, which, to a
great part, is avoided with use of the transcervical approach.
Further study in larger patient populations is needed to
confirm this hypothesis.
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